- Home
- ASRT vs VATE Comparison
ASRT vs VATE Comparison
Compare ASRT & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- VATE
- Stock Information
- Founded
- ASRT 1995
- VATE 1994
- Country
- ASRT United States
- VATE United States
- Employees
- ASRT N/A
- VATE N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- ASRT Health Care
- VATE Industrials
- Exchange
- ASRT Nasdaq
- VATE Nasdaq
- Market Cap
- ASRT 79.1M
- VATE 63.3M
- IPO Year
- ASRT 1997
- VATE 1996
- Fundamental
- Price
- ASRT $0.91
- VATE $4.69
- Analyst Decision
- ASRT Strong Buy
- VATE
- Analyst Count
- ASRT 1
- VATE 0
- Target Price
- ASRT $3.00
- VATE N/A
- AVG Volume (30 Days)
- ASRT 316.5K
- VATE 43.0K
- Earning Date
- ASRT 11-10-2025
- VATE 11-05-2025
- Dividend Yield
- ASRT N/A
- VATE N/A
- EPS Growth
- ASRT N/A
- VATE N/A
- EPS
- ASRT N/A
- VATE N/A
- Revenue
- ASRT $117,099,000.00
- VATE $995,000,000.00
- Revenue This Year
- ASRT N/A
- VATE N/A
- Revenue Next Year
- ASRT $6.75
- VATE N/A
- P/E Ratio
- ASRT N/A
- VATE N/A
- Revenue Growth
- ASRT N/A
- VATE N/A
- 52 Week Low
- ASRT $0.51
- VATE $3.25
- 52 Week High
- ASRT $1.16
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- ASRT 58.21
- VATE 45.07
- Support Level
- ASRT $0.87
- VATE $4.53
- Resistance Level
- ASRT $0.93
- VATE $4.98
- Average True Range (ATR)
- ASRT 0.05
- VATE 0.33
- MACD
- ASRT -0.00
- VATE -0.02
- Stochastic Oscillator
- ASRT 54.32
- VATE 21.53
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.